Literature DB >> 1829698

Domains of the adenovirus E1A protein required for oncogenic activity are also required for dissociation of E2F transcription factor complexes.

P Raychaudhuri1, S Bagchi, S H Devoto, V B Kraus, E Moran, J R Nevins.   

Abstract

Recent experiments have shown that the cellular E2F transcription factor is found in complexes with cellular proteins and that one such complex contains the cyclin-A protein. Isolation of a cellular activity, which we term E2F-BF, can reconstitute the E2F-cyclin-A complex and has permitted a more detailed analysis of the mechanism of E1A dissociation. Through the analysis of a series of E1A mutants, we find that sequences in conserved region 1 (CR1) and conserved region 2 (CR2) are important for dissociation of the E2F complex, whereas amino-terminal sequences are not required. In contrast to the requirements for dissociation, only the CR1 sequences are required to block formation of the complex if E1A is added when the components are combined. We have also identified an activity, termed E2F-I, that inhibits E2F binding to DNA, again apparently through the formation of a complex with E2F. This inhibitory activity is also blocked by E1A, dependent on the same elements of the E1A protein that disrupt the interaction with E2F-BF. Because the E1A sequences that are important for releasing E2F from these interactions are also sequences necessary for oncogenesis, we suggest that this activity may be a critical component of the transforming activity of E1A.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1829698     DOI: 10.1101/gad.5.7.1200

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  72 in total

1.  Induction of AP-1 DNA-binding activity and c-fos mRNA by the adenovirus 243R E1A protein and cyclic AMP requires domains necessary for transformation.

Authors:  R W Gedrich; S T Bayley; D A Engel
Journal:  J Virol       Date:  1992-10       Impact factor: 5.103

2.  Transforming growth factor beta 1 (TGF beta 1) reduces cellular levels of p34cdc2, and this effect is abrogated by adenovirus independently of the E1A-associated pRB binding activity.

Authors:  S E Abraham; M C Carter; E Moran
Journal:  Mol Biol Cell       Date:  1992-06       Impact factor: 4.138

3.  Identification of a 60-kilodalton Rb-binding protein, RBP60, that allows the Rb-E2F complex to bind DNA.

Authors:  S K Ray; M Arroyo; S Bagchi; P Raychaudhuri
Journal:  Mol Cell Biol       Date:  1992-10       Impact factor: 4.272

4.  Promoter-specific trans-activation by the adenovirus E1A12S product involves separate E1A domains.

Authors:  V B Kraus; E Moran; J R Nevins
Journal:  Mol Cell Biol       Date:  1992-10       Impact factor: 4.272

5.  DNA-binding properties of the E1A-associated 300-kilodalton protein.

Authors:  Y Rikitake; E Moran
Journal:  Mol Cell Biol       Date:  1992-06       Impact factor: 4.272

6.  Adenovirus E1A makes two distinct contacts with the retinoblastoma protein.

Authors:  N Dyson; P Guida; C McCall; E Harlow
Journal:  J Virol       Date:  1992-07       Impact factor: 5.103

7.  Cell cycle regulation of the cyclin A gene promoter is mediated by a variant E2F site.

Authors:  A Schulze; K Zerfass; D Spitkovsky; S Middendorp; J Bergès; K Helin; P Jansen-Dürr; B Henglein
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-21       Impact factor: 11.205

8.  Complementary functions of E1a conserved region 1 cooperate with conserved region 3 to activate adenovirus serotype 5 early promoters.

Authors:  H K Wong; E B Ziff
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

9.  Growth arrest by induction of p53 in DNA damaged keratinocytes is bypassed by human papillomavirus 16 E7.

Authors:  G W Demers; S A Foster; C L Halbert; D A Galloway
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-10       Impact factor: 11.205

10.  Regions of the retinoblastoma gene product required for its interaction with the E2F transcription factor are necessary for E2 promoter repression and pRb-mediated growth suppression.

Authors:  S W Hiebert
Journal:  Mol Cell Biol       Date:  1993-06       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.